Compound page for C00017 (Protein, [Receptor-protein]): EzCatDB EzCatDB

Compound page for C00017: Protein, [Receptor-protein]

Top page for Compound List

Formula: C4H6N2O3R2(C2H2NOR)n




There are 87 entries for this compound.
  • M00335: 2.7.10.2, 2.7.11.1 ; Activated CDC42 kinase 1 (Catalytic domain; 1.10.510.10)
  • T00255: 2.7.11.11 ; cAMP-dependent protein kinase catalytic subunit alpha (Catalytic domain; )
  • M00221: 2.7.11.13 ; Protein kinase C delta type (Catalytic domain; )
  • M00197: 2.7.11.1 ; Casein kinase II subunit alpha (Catalytic domain; 1.10.510.10, 3.30.200.20)
  • M00196: 2.7.11.22 ; Cyclin-dependent kinase 5 (Catalytic domain; 1.10.510.10, 3.30.200.20)
  • T00224: 2.7.11.30 ; TGF-beta receptor type-1 (Catalytic domain; 1.10.510.10)
  • M00021: 2.7.7.48, 3.4.21.91 ; Genome polyprotein (Catalytic domain; )
  • M00217: 2.7.7.48, 3.4.22.28, 3.4.22.29, 3.6.1.15 ; Genome polyprotein (Catalytic domain; 2.40.10.10)
  • M00216: 2.7.7.48, 3.4.22.28, 3.4.22.46, 3.6.1.15 ; Genome polyprotein (Catalytic domain; 2.40.10.10)
  • M00209: 2.7.7.48, 3.4.22.28, 3.6.1.15 ; Genome polyprotein (Catalytic domain; 2.40.10.10)
  • M00206: 2.7.7.49, 3.1.26.4, 3.4.23.-, 3.6.1.23 ; Pol polyprotein (Catalytic domain; 2.40.70.10, 2.70.40.10)
  • D00471: 2.7.7.7, 2.7.7.49, 3.1.26.4, 3.4.23.16 ; Gag-Pol polyprotein (Catalytic domain; 2.40.70.10)
  • M00166: 2.7.7.7, 2.7.7.49, 3.1.26.4, 3.4.23.47 ; Gag-Pol polyprotein (Catalytic domain; 2.40.70.10, 3.30.70.270, 3.30.420.10)
  • S00350: 3.1.2.22 ; Palmitoyl-protein thioesterase 1 (Catalytic domain; 3.40.50.1820)
  • D00154: 3.1.3.16, 3.1.3.48, 3.1.3.67 ; Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (Catalytic domain; 3.90.190.10)
  • S00458: 3.1.3.16, 3.1.3.48 ; Dual specificity protein phosphatase 3 (Catalytic domain; 3.90.190.10)
  • D00152: 3.1.3.16 ; Protein phosphatase 1A (Catalytic domain; 3.60.40.10)
  • D00151: 3.1.3.16 ; Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform (Catalytic domain; 3.60.21.10)
  • D00469: 3.1.3.16 ; Serine/threonine-protein phosphatase 5 (Catalytic domain; )
  • S00406: 3.4.11.10 ; Bacterial leucyl aminopeptidase (Catalytic domain; 3.40.630.10)
  • D00193: 3.4.17.15 ; Carboxypeptidase A2 (Catalytic domain; 3.40.630.10)
  • S00407: 3.4.17.18 ; Carboxypeptidase T (Catalytic domain; 3.40.630.10)
  • D00467: 3.4.17.1 ; Carboxypeptidase A (Catalytic domain; 3.40.630.10)
  • D00512: 3.4.17.2 ; Carboxypeptidase B (Catalytic domain; 3.40.630.10)
  • S00408: 3.4.19.3 ; Pyrrolidone-carboxylate peptidase (Catalytic domain; 3.40.630.20)
  • S00296: 3.4.21.100 ; Pseudomonalisin (Catalytic domain; 3.40.50.200)
  • T00411: 3.4.21.108 ; Serine protease HTRA2 (Catalytic domain; 2.40.10.10)
  • M00348: 3.4.21.109 ; Suppressor of tumorigenicity 14 protein (Catalytic domain; 2.40.10.10)
  • D00851: 3.4.21.19 ; Glutamyl endopeptidase (Catalytic domain; 2.40.10.10)
  • D00426: 3.4.21.20 ; Cathepsin G (Catalytic domain; 2.40.10.10)
  • D00211: 3.4.21.32 ; Brachyurin (Catalytic domain; 2.40.10.10)
  • D00212: 3.4.21.35 ; Glandular kallikrein (Catalytic domain; 2.40.10.10)
  • M00181: 3.4.21.35 ; Kallikrein 1-related peptidase b3 (Catalytic domain; 2.40.10.10)
  • D00497: 3.4.21.35 ; Tonin (Catalytic domain; 2.40.10.10)
  • D00214: 3.4.21.36 ; Elastase-1 (Catalytic domain; 2.40.10.10)
  • D00216: 3.4.21.37 ; Leukocyte elastase (Catalytic domain; 2.40.10.10)
  • D00430: 3.4.21.50 ; Protease 1 (Catalytic domain; 2.40.10.10)
  • D00431: 3.4.21.59 ; Tryptase beta-2 (Catalytic domain; 2.40.10.10)
  • D00219: 3.4.21.62 ; Subtilisin Carlsberg (Catalytic domain; 3.40.50.200)
  • S00295: 3.4.21.64 ; Proteinase K (Catalytic domain; 3.40.50.200)
  • S00519: 3.4.21.66 ; Thermitase (Catalytic domain; 3.40.50.200)
  • M00212: 3.4.21.69 ; Vitamin K-dependent protein C (Catalytic domain; 2.40.10.10)
  • D00433: 3.4.21.76 ; Myeloblastin (Catalytic domain; 2.40.10.10)
  • D00852: 3.4.21.78 ; Granzyme A (Catalytic domain; 2.40.10.10)
  • D00855: 3.4.21.79 ; Granzyme B (Catalytic domain; 2.40.10.10)
  • D00434: 3.4.21.80 ; Streptogrisin-A (Catalytic domain; 2.40.10.10)
  • D00224: 3.4.21.81 ; Streptogrisin-B (Catalytic domain; 2.40.10.10)
  • D00435: 3.4.21.82 ; Glutamyl endopeptidase 2 (Catalytic domain; 2.40.10.10)
  • D00510: 3.4.21.88 ; LexA repressor (Catalytic domain; 2.10.109.10)
  • S00447: 3.4.22.14 ; Actinidain (Actinidin) (EC 3.4.22.14)AltName: Allergen=Act c 1; (Catalytic domain; 3.90.70.10)
  • S00518: 3.4.22.15 ; Cathepsin L1 (Catalytic domain; 3.90.70.10)
  • S00448: 3.4.22.16 ; Cathepsin H (Catalytic domain; 3.90.70.10)
  • S00445: 3.4.22.1 ; Cathepsin B (Catalytic domain; 3.90.70.10)
  • S00449: 3.4.22.25 ; Papaya proteinase 4 (Catalytic domain; 3.90.70.10)
  • S00450: 3.4.22.30 ; Caricain (Catalytic domain; 3.90.70.10)
  • T00257: 3.4.22.37 ; Gingipain R2 (Catalytic domain; 3.40.50.1460)
  • S00451: 3.4.22.38 ; Cathepsin K (Catalytic domain; 3.90.70.10)
  • S00446: 3.4.22.6 ; Chymopapain (Catalytic domain; 3.90.70.10)
  • D00436: 3.4.23.1 ; Pepsin A (Catalytic domain; 2.40.70.10)
  • D00439: 3.4.23.20 ; Penicillopepsin (Catalytic domain; 2.40.70.10)
  • D00440: 3.4.23.21 ; Rhizopuspepsin (Catalytic domain; 2.40.70.10)
  • D00441: 3.4.23.22 ; Endothiapepsin (Catalytic domain; 2.40.70.10)
  • D00442: 3.4.23.23 ; Mucorpepsin (Catalytic domain; 2.40.70.10)
  • D00443: 3.4.23.24 ; Candidapepsin (Catalytic domain; 2.40.70.10)
  • D00231: 3.4.23.25 ; Saccharopepsin (Catalytic domain; 2.40.70.10)
  • D00444: 3.4.23.39 ; Plasmepsin-2 (Catalytic domain; 2.40.70.10)
  • D00437: 3.4.23.3 ; Gastricsin (Catalytic domain; 2.40.70.10)
  • D00445: 3.4.23.40 ; Phytepsin (Catalytic domain; 2.40.70.10)
  • D00423: 3.4.23.4 ; Chymosin (Catalytic domain; 2.40.70.10)
  • D00484: 3.4.23.5 ; Cathepsin D (Catalytic domain; 2.40.70.10)
  • D00529: 3.4.23.- ; Pepsin-2B (Catalytic domain; 2.40.70.10)
  • S00394: 3.4.24.21 ; Astacin (Catalytic domain; 3.40.390.10)
  • S00395: 3.4.24.23 ; Matrilysin (Catalytic domain; 3.40.390.10)
  • M00101: 3.4.24.24 ; 72 kDa type IV collagenase (Catalytic domain; 3.40.390.10)
  • D00233: 3.4.24.26 ; Pseudolysin (Catalytic domain; 1.10.390.10, 3.10.170.10)
  • D00234: 3.4.24.27 ; Thermolysin (Catalytic domain; 1.10.390.10, 3.10.170.10)
  • D00235: 3.4.24.28 ; Bacillolysin (Catalytic domain; 1.10.390.10, 3.10.170.10)
  • D00480: 3.4.24.29 ; Zinc metalloproteinase aureolysin (Catalytic domain; 1.10.390.10, 3.10.170.10)
  • S00397: 3.4.24.34 ; Neutrophil collagenase (Catalytic domain; 3.40.390.10)
  • M00029: 3.4.24.36 ; Leishmanolysin (Catalytic domain; 3.10.170.20, 3.90.132.10)
  • D00236: 3.4.24.40 ; Serralysin (Catalytic domain; 3.40.390.10)
  • S00398: 3.4.24.42 ; Zinc metalloproteinase atrolysin-D (Catalytic domain; 3.40.390.10)
  • S00399: 3.4.24.46 ; Zinc metalloproteinase adamalysin-2 (Catalytic domain; 3.40.390.10)
  • M00185: 3.4.24.68 ; Tetanus toxin (Catalytic domain; 3.90.1240.10)
  • D00232: 3.4.24.7 ; Interstitial collagenase (Catalytic domain; 3.40.390.10)
  • M00123: 3.4.25.1 ; Proteasome component PRE5 (Catalytic domain; 3.60.20.10)
  • M00174: 3.4.25.1 ; Proteasome subunit alpha (Catalytic domain; 3.60.20.10)
    • Copyright: Nozomi Nagano, JST & CBRC-AIST
    Funded by PRESTO/Japan Science and Technology Agency (JST) (December 2001 - November 2004)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2006)
    Funded by Grant-in-Aid for Scientific Research (B)/Japan Society for the Promotion of Science (JSPS) (April 2005 - March 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (September 2005 - September 2008)
    Funded by BIRD/Japan Science and Technology Agency (JST) (October 2007 - September 2010)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2011 - March 2012)
    Funded by Grant-in-Aid for Publication of Scientific Research Results/Japan Society for the Promotion of Science (JSPS) (April 2012 - March 2013)
    Supported by the commission for the Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI) (October 2012 - )